Opportunity
DIBBS #SPE2DP-26-T-3314
Procurement of Moxifloxacin Hydrochloride Tablets for Military Delivery
Posted
May 08, 2026
Respond By
May 13, 2026
Identifier
SPE2DP-26-T-3314
NAICS
424210
This opportunity from the Defense Logistics Agency Troop Support Medical Supply Chain Pharm FSA seeks Moxifloxacin Hydrochloride tablets for military and naval delivery locations. - Government Buyer: - Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharm FSA, Philadelphia, PA - OEMs and Vendors: - TEVA PHARMACEUTICALS USA, INC. - RISING PHARMA HOLDINGS, INC. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN 6505-01-503-4772 - TEVA: Part number NDC00093-7387-56 (14 bottles) - RISING: Part number NDC57237-0156-30 (12 bottles) - Delivery Requirements: - Total quantity: 26 bottles (14 + 12) - Delivery within 20 days from award - Delivery locations: Fort Campbell, KY and USS Paul Hamilton DDG 60 (FPO AP) - Notable Requirements: - Packaging and marking must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1 - Compliance with Buy American Act, hazardous material labeling, and cybersecurity requirements - Only TEVA and RISING are approved OEMs for this NSN
Description
MOXIFLOXACIN HYDROC (QTY: 14, NSN: 6505-01-503-4772, Purchase Request: 7016677258) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7016699423) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.